Recent Posts
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
- Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
- Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs
- Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
- Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
- Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs
- Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.
Recent Tweets
-
Time to update your Avada theme? Your plugins? Update your plugins, schedule regular backups, apply all patches. If… twitter.com/i/web/status/1…
1 day ago -
"Without continual growth and progress, such words as improvement, achievement, and success have no meaning." :: Be… twitter.com/i/web/status/1…
5 days ago -
Avada 5.7.2 has been released & includes an important security fix, continued Gutenberg compatibility assurance, ac… twitter.com/i/web/status/1…
6 days ago
Recent Comments